Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Esperanza Pozo-Agundo"'
Autor:
Mario Sanchez-Canteli, Francisco Hermida-Prado, Christian Sordo-Bahamonde, Irene Montoro-Jiménez, Esperanza Pozo-Agundo, Eva Allonca, Aitana Vallina-Álvarez, César Álvarez-Marcos, Segundo Gonzalez, Juana M. García-Pedrero, Juan P. Rodrigo
Publikováno v:
Biomedicines, Vol 8, Iss 12, p 535 (2020)
Lectin-like transcript 1 (LLT1) expression by tumor cells contributes to immune evasion, thereby emerging as a natural killer (NK) cell-mediated immunotherapeutic target. This study is the first to investigate LLT1 expression (encoded by CLEC2D gene)
Externí odkaz:
https://doaj.org/article/7fda5dcc61ee4e8198febecf30db1b48
Autor:
Francisco Hermida-Prado, Irene Montoro-Jiménez, Eva Allonca, Mario Sánchez-Canteli, Segundo Gonzalez, Esperanza Pozo-Agundo, Christian Sordo-Bahamonde, Juan P. Rodrigo, César Álvarez-Marcos, Aitana Vallina-Álvarez, Juana M. García-Pedrero
Publikováno v:
Biomedicines
Scopus
RUO. Repositorio Institucional de la Universidad de Oviedo
instname
Biomedicines, Vol 8, Iss 535, p 535 (2020)
RUO: Repositorio Institucional de la Universidad de Oviedo
Universidad de Oviedo (UNIOVI)
Volume 8
Issue 12
Scopus
RUO. Repositorio Institucional de la Universidad de Oviedo
instname
Biomedicines, Vol 8, Iss 535, p 535 (2020)
RUO: Repositorio Institucional de la Universidad de Oviedo
Universidad de Oviedo (UNIOVI)
Volume 8
Issue 12
Lectin-like transcript 1 (LLT1) expression by tumor cells contributes to immune evasion, thereby emerging as a natural killer (NK) cell-mediated immunotherapeutic target. This study is the first to investigate LLT1 expression (encoded by CLEC2D gene)
Autor:
Mario Sánchez-Canteli, Christian Sordo-Bahamonde, Eva Allonca, Francisco Hermida-Prado, César Álvarez-Marcos, Juana M. García-Pedrero, Juan P. Rodrigo, Esperanza Pozo-Agundo, Irene Montoro-Jiménez, Aitana Vallina-Álvarez, Segundo Gonzalez
Publikováno v:
Oral Oncology. 118:8
Autor:
Mónica Álvarez-Fernández, César Álvarez-Marcos, Juan P. Rodrigo, Rocío Granda-Díaz, Esperanza Pozo-Agundo, Juana M. García-Pedrero, Daniel Pedregal-Mallo, Eva Allonca, Francisco Hermida-Prado, Irene Montoro-Jiménez
Publikováno v:
Scopus
RUO: Repositorio Institucional de la Universidad de Oviedo
Universidad de Oviedo (UNIOVI)
Cancers
Volume 12
Issue 7
RUO. Repositorio Institucional de la Universidad de Oviedo
Universidad de las Islas Baleares
Cancers, Vol 12, Iss 1794, p 1794 (2020)
RUO: Repositorio Institucional de la Universidad de Oviedo
Universidad de Oviedo (UNIOVI)
Cancers
Volume 12
Issue 7
RUO. Repositorio Institucional de la Universidad de Oviedo
Universidad de las Islas Baleares
Cancers, Vol 12, Iss 1794, p 1794 (2020)
Cancer stem cells (CSCs) play major roles in tumor initiation, progression, and resistance to cancer therapy. Several CSC markers have been studied in head and neck squamous cell carcinomas (HNSCC), including the pluripotency factors NANOG, SOX2, and